Drug Shortage Report for DILTIAZEM HYDROCHLORIDE INJECTION
| Report ID | 189684 |
| Drug Identification Number | 02514095 |
| Brand name | DILTIAZEM HYDROCHLORIDE INJECTION |
| Common or Proper name | Diltiazem Hydrochloride Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 x 10 mL vial / fiole |
| ATC code | C08DB |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-05-26 |
| Estimated end date | |
| Actual end date | 2023-09-01 |
| Shortage status | Resolved |
| Updated date | 2023-09-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | [email protected] - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.